Intramyocardial Injection of Serca2a‐Expressing Lentivirus Improves Myocardial Function in Doxorubicin‐Induced Heart Failure

ConclusionsSERCA2a gene transfer improves significantly left ventricle function and dimensions in doxorubicin‐induced cardiomyopathy thus making LV‐SERCA2a gene transfer an attractive treatment modality for doxorubicin‐induced heart failure.

Source: The Journal of Gene Medicine - December 31, 2015 Category: Genetics & Stem Cells Authors: Minttu Mattila, Juha Koskenvuo, Mirva Söderström, Kim Eerola, Mikko Savontaus Tags: Research Article Source Type: research